Conversely, the number of CD69+ NK cells in the tumor 36 h post-treatment was only significantly increased when NDV was administered as a monotherapy; however, in the TdLNs there was a significant increase in the number of CD69+ NK cells in the combination therapy treatment group, which could be due to increased NK cell trafficking to the TdLNs. This evidence concerns the gene CD69 and neoplasm.